DE68905657D1 - Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. - Google Patents

Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.

Info

Publication number: DE68905657D1
Authority: DE; Germany
Prior art keywords: treatment; production; medicinal product; certain communication; arginine aspartate
Prior art date: 1988-05-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE8989450007T

Other languages

English (en)

Other versions

DE68905657T2 (de

Inventor

Georges Cehovic

Emmanuel Panconi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Meda Pharma SAS

Original Assignee

Cortial SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-05-09

Filing date

1989-04-05

Publication date

1993-05-06

1989-04-05 Application filed by Cortial SA filed Critical Cortial SA

1993-05-06 Application granted granted Critical

1993-05-06 Publication of DE68905657D1 publication Critical patent/DE68905657D1/de

1993-08-12 Publication of DE68905657T2 publication Critical patent/DE68905657T2/de

2009-04-06 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DE8989450007T 1988-05-09 1989-04-05 Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen. Expired - Lifetime DE68905657T2 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/191,391 US5019558A (en)	1988-05-09	1988-05-09	Method for treating memory disturbances using arginine aspartate

Publications (2)

Publication Number	Publication Date
DE68905657D1 true DE68905657D1 (de)	1993-05-06
DE68905657T2 DE68905657T2 (de)	1993-08-12

Family

ID=22705302

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8989450007T Expired - Lifetime DE68905657T2 (de)	1988-05-09	1989-04-05	Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.

Country Status (5)

Country	Link
US (1)	US5019558A (de)
EP (1)	EP0342139B1 (de)
JP (1)	JPH0256420A (de)
DE (1)	DE68905657T2 (de)
ES (1)	ES2054077T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5478560A (en) *	1990-10-19	1995-12-26	Shiseido Company Ltd.	External dermatological composition
SE468881B (sv) *	1991-01-09	1993-04-05	Kabi Pharmacia Ab	Anvaendning av vissa foereningar foer framstaellning av laekemedel foer behandling av endotoxininducerade effekter samt saett att avlaegsna endotoxiner ur diverse loesningar
US5798371A (en) *	1995-01-13	1998-08-25	Komissarova; Irina Alexeevna	Pharmaceutical composition endowed with an antialcoholic and nootropic effect
RU2097034C1 (ru) *	1995-01-13	1997-11-27	Ирина Алексеевна Комиссарова	Фармацевтический препарат антиалкогольного и ноотропного действия
JP2004123564A (ja) *	2002-09-30	2004-04-22	Inst Of Physical & Chemical Res	中枢機能改善用アミノ酸組成物
HUP0401422A2 (en)	2004-07-15	2006-04-28	G Laszlo Meszaros	Use of l-arginine as vasoaktive ingredient absorbing through skin for external application
CN108689887A (zh) *	2018-04-23	2018-10-23	宜兴市前成生物有限公司	一种工业化生产l-精氨酸-l-天门冬氨酸的方法
KR102315140B1 (ko) *	2020-01-15	2021-10-20	주식회사 휴메딕스	알지닌 아스파테이트를 포함하는 노인성 체취 억제용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR873265A (fr) *	1941-02-13	1942-07-03	Const Aeronautiques De L Ouest	Perfectionnements apportés aux gazogènes, destines notamment à alimenter des moterrs fixes
FR106F (de) *	1964-12-21
FR2568124B1 (fr) *	1984-07-24	1988-12-09	Cortial	Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine

1988
- 1988-05-09 US US07/191,391 patent/US5019558A/en not_active Expired - Lifetime
1989
- 1989-04-05 EP EP89450007A patent/EP0342139B1/de not_active Expired - Lifetime
- 1989-04-05 DE DE8989450007T patent/DE68905657T2/de not_active Expired - Lifetime
- 1989-04-05 ES ES89450007T patent/ES2054077T3/es not_active Expired - Lifetime
- 1989-05-08 JP JP1114881A patent/JPH0256420A/ja active Pending

Also Published As

Publication number	Publication date
DE68905657T2 (de)	1993-08-12
EP0342139A3 (en)	1990-09-19
EP0342139B1 (de)	1993-03-31
US5019558A (en)	1991-05-28
EP0342139A2 (de)	1989-11-15
JPH0256420A (ja)	1990-02-26
ES2054077T3 (es)	1994-08-01

Similar Documents

Publication	Publication Date	Title
DE69310065D1 (de)	1997-05-28	Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose
DE3484055D1 (de)	1991-03-07	Verwendung von ubidecarenon zur herstellung eines medikaments zur behandlung von durch radiotherapie hervorgerufenen geschwueren.
DE69113386D1 (de)	1995-11-02	Herstellung von Medikamenten zur Behandlung von Asthma, unter Verwendung von (S)-Alpha-Fluoromethyl-Histidin und dessen Estern.
DE3785740D1 (de)	1993-06-09	Verwendung von carboxamid-verbindungen zur herstellung eines arzneimittels zur behandlung der hyperlipaemie.
DE68924714D1 (de)	1995-12-07	Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen.
DE3483279D1 (de)	1990-10-31	Verwendung einer sekretolytisch wirkenden substanz zur herstellung eines antischnarchmittels und zur bekaempfung des schnarchphaenomens.
DE3681144D1 (de)	1991-10-02	Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.
DE3583220D1 (de)	1991-07-18	Verwendung von dipeptidderivaten fuer die herstellung von arzneimitteln zur behandlung von an amyotropher lateralsklerose erkrankten.
ATE246518T1 (de)	2003-08-15	Egr-1 zur herstellung eines medikamentes zur behandlung von wunden
DE69233725D1 (de)	2008-03-27	Verwendung von DNA oder RNA zur Herstellung eines Medikaments zur Behandlung von Tumoren
ATE27914T1 (de)	1987-07-15	Verwendung von n-acetyl(alpha, beta) aspartylglutaminsaeure zur herstellung eines arzneimittels mit anti-allergischer wirkung zur lokalen verabreichung.
DE58906613D1 (de)	1994-02-17	Verfahren zur Herstellung von orthodontischen Teilen.
DE68905657D1 (de)	1993-05-06	Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE3481057D1 (de)	1990-02-22	2-sulfamoylbenzo(b)thiophen-derivate, ihre herstellung und pharmazeutische zubereitung zur behandlung von erhoehtem augeninnendruck.
DE3768150D1 (de)	1991-04-04	Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
DE3766619D1 (de)	1991-01-17	Verwendung von dicarbonsaeuren mit 7-13 kohlenstoffatomen oder physiologisch vertraeglichen salzen davon zur herstellung eines arzneimittels zur topischen behandlung von rosazea.
ATE136465T1 (de)	1996-04-15	Verwendung von gibberellinen zur herstellung eines arzneimittels zur behandlung von prostatitis
DE58901037D1 (de)	1992-04-30	Vorrichtung zur herstellung von klareisstuecken.
DE69103865D1 (de)	1994-10-13	Verwendung von tetrahydro-isoquinoline-derivate zur herstellung eines arzneimittels mit antitumoraler wirkung.
DE69007065D1 (de)	1994-04-07	Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE3873210D1 (de)	1992-09-03	Verwendung von benzylpyridin-derivaten zur herstellung eines arzneimittels zur behandlung der demenz.
DE3686097D1 (de)	1992-08-27	Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
DE69531554D1 (de)	2003-09-25	Verwendung von inosittriphosphat zur herstellung von arzneimitteln
DE3483944D1 (de)	1991-02-21	Verwendung von selektiv peripheren dopamin-antagonisten zur herstellung eines arzneimittels zur topischen behandlung von okularer hypertension.
DE69300037D1 (de)	1995-02-09	Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.

Legal Events

Date	Code	Title	Description
1994-04-28	8364	No opposition during term of opposition
1998-02-26	8327	Change in the person/name/address of the patent owner	Owner name: ASTA MEDICA S.A., MERIGNAC, FR
2003-07-10	8327	Change in the person/name/address of the patent owner	Owner name: VIATRIS PHARMACEUTICALS S.A., MERIGNAC, FR
2007-09-27	8327	Change in the person/name/address of the patent owner	Owner name: MEDA PHARMA, MERIGNAC, FR